ECTRIMS 2019: Efficacy of satralizumab as monotherapy

Jeffrey L Bennett | ECTRIMS 2019 | 13. September 2019

Speaker: Jeffrey L Bennett

Jeffrey L Bennett present in this MEDtalk the result of a randomised, double-blind, Phase 3 clinical trial comparing satralizumab monotherapy with placebo according to protocol-defined relapse.